Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01266031
Title Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

mixed oligodendroglioma-astrocytoma

malignant astrocytoma

high grade glioma

glioblastoma

adult oligodendroglioma

gliosarcoma

Therapies

Bevacizumab + Vorinostat

Bevacizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.